Toth Financial Advisory’s Ascendis Pharma A/S ASND Stock Holding History

Toth Financial Advisory’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.57M	Buy	5,880 +430	+8%	+$100K	0.15%	121
2026 Q1	$1.25M	Buy	5,450 +810	+17%	+$182K	0.14%	122
2025 Q4	$989K	Buy	4,640 +4,045	+680%	+$835K	0.11%	134
2025 Q3	$118K	Buy	595 +150	+34%	+$28K	0.01%	252
2025 Q2	$76.8K	Sell	445 -4,890	-92%	-$797K	0.01%	269
2025 Q1	$832K	Buy	+5,335	New	+$762K	0.1%	135

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Toth Financial Advisory's ASND Position: Q2 2026 in Review

Toth Financial Advisory increased its Ascendis Pharma A/S (ASND) stake by 7.9% in Q2 2026, buying an estimated $100K and bringing the position to 5,880 shares worth $1.57M. The position accounts for 0.15% of the portfolio, ranked #121.

Toth Financial Advisory first reported a position in ASND in Q1 2025 and has held it in 6 quarters since. 312 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

Toth Financial Advisory held 5,880 shares of Ascendis Pharma A/S worth $1.57M as of Q2 2026.
Toth Financial Advisory bought 430 Ascendis Pharma A/S shares in Q2 2026, an estimated $100K.
Ascendis Pharma A/S made up 0.15% of Toth Financial Advisory's portfolio in Q2 2026, its #121 holding.
Toth Financial Advisory first reported a position in Ascendis Pharma A/S in Q1 2025 and has held it in 6 quarters since.
312 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Toth Financial Advisory's 13F filing for Q2 2026, filed 14 Jul 2026.